Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
24 March 2024
23 March 2024
|
m 12:25 | B-cell acute lymphoblastic leukemia 3 changes history -54 [Jwarner (3×)] | |||
m |
|
12:25 (cur | prev) +2,810 Jwarner talk contribs →Relapsed or refractory | |||
m |
|
12:25 (cur | prev) -2,834 Jwarner talk contribs →Cytarabine & Mitoxantrone (MC) {{#subobject:6237f0|Regimen=1}} | |||
m |
|
12:25 (cur | prev) -30 Jwarner talk contribs →Inotuzumab ozogamicin monotherapy {{#subobject:d90806|Regimen=1}} |
m 12:13 | Diffuse large B-cell lymphoma diffhist -27 Jwarner talk contribs |
22 March 2024
20:27 | B-cell acute lymphoblastic leukemia, Ph-positive diffhist +1,613 Jwarner talk contribs →Upfront induction therapy |
m 16:27 | Diffuse large B-cell lymphoma diffhist +45 Jwarner talk contribs →R-DHAOx {{#subobject:0d0c67|Regimen=1}} |
m 16:03 | B-cell acute lymphoblastic leukemia, pediatric diffhist +1 Jwarner talk contribs →Interim Maintenance, I with HD MTX {{#subobject:98346f|Variant=1}} |